Get Your Burning Aseptic Questions Answered by Regulators
Matthew P. VonEsch
Marking its 27th year, the annual ISPE Aseptic Conference continues to be the place to go to for the latest and greatest in barrier/isolation technology, small and large scale aseptic manufacturing, robotics, and disposables. The conference presents fantastic opportunities to interact with pharmaceutical industry leaders, experts, and regulatory agencies. The pinnacle of the conference remains the regulatory discussion panel, where attendees and colleagues with interest can submit questions for the regulators in attendance to answer. The 2018 ISPE Aseptic Conference will be held in Reston, Virginia March 6-7, with the following regulatory representative taking part in the annual tradition:
Robert Sausville, Director, FDA/CBER/OCBR/DCM
Rebecca Dombrowski, USFDA/CDER/OPQ/OPF/DIA/IABI
Lynne Ensor, PhD, CDER/OPQ/OPF/DMA
Rick Friedman, USFDA/ CDER/OC/OMQ
CDR Jeremy Wally, PhD, USFDA/CBER/OCBQ/DIS
Thomas Arista, FDA/ORA/ORO/DMPTO
The 2018 ISPE Aseptic Conference presents a fantastic opportunity to interact with pharmaceutical industry leaders, experts, and regulatory agencies. Information shared during the regulatory Q&A session will be available for attendees after the conference. Although we must all be reminded that as attendees, the participants comments are considered opinions only, and cannot be viewed as statements by the FDA; however they do provide insight into current directions and risk points to be considered when operating aseptic facilities. The Q&A session is open to all conference attendees, with the question pool being generated from conference attendees via the ISPE website, additionally during the Q&A session there is an open microphone option for brave attendees to ask their questions directly.
With the conference quickly approaching, we look forward to hosting and seeing you there.
Matthew VonEsch is the AVP of Xeno and Regenerative Medicine Operations at United Therapeutics. Beginning with Wyeth Biopharma, followed by Human Genome Sciences, MedImmune, United...
Are you considering joining ISPE? Or maybe you’ve recently joined the society or are a longtime member looking to better understand all the benefits available to you. If so, you’ve come to the right place!
ATMPs are based on genes, cells or tissues delivered to patients to provide a therapeutic benefit based on a specific target of interest. Often referred to as ‘Personalised Medicine’. A sector of healthcare that is rapidly evolving and expanding with some unique challenges such as microbial contamination and product variability. Traditional manufacturing processes are for synthetically derived...
GAMP® 5 Second Edition is here! Since its publication, GAMP® 5 has been far and away the leading international guidance on GxP computerized systems validation and compliance, and it was time to update our guidance to...